Biomarkers of Diet-microbiota Interactions in Irritable Bowel Syndrome
NCT04364750 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2026-04-13
Summary
Most patients suffering from the irritable bowel syndrome (IBS) report that ingestion of certain foods is a major trigger of symptoms, but the reason is unclear. Previous studies have shown that foods containing poorly absorbed carbohydrates (FODMAPs) are fermented by the bacteria in our bowels and these cause symptoms in some but not all patients. Gut bacteria are capable of producing various products, such as neuroimmune mediator histamine, that may be related to IBS symptoms. Our recent data suggest that consumption of FODMAPs promotes production of bacterial histamine.
The main objective of this study is to investigate bacterial production of histamine and its relationship to IBS symptoms. The study will involve 6 weeks on a low-FODMAP diet with three three-day interventions consisting of High- or Low-FODMAP drinks along with probiotics or placebo capsules. The patient's bacteria and metabolites will be analyzed at various time points.
Conditions
- Irritable Bowel Syndrome
Interventions
- DIETARY_SUPPLEMENT
-
L-Histidine
1 capsule (0.6g) twice daily
- DIETARY_SUPPLEMENT
-
High-FODMAP beverage
High-FODMAP beverage (10g of fermentable carbohydrates) consumed twice daily.
- DIETARY_SUPPLEMENT
-
Low-FODMAP beverage
Low-FODMAP beverage (10g glucose) consumed twice daily.
- DIETARY_SUPPLEMENT
-
Lactobacillus acidophilus CL1285, L. casei LBC80R and L. rhamnosus CLR2.
Total of 50 billion CFU/capsule taken twice daily.
- OTHER
-
Placebo
Enteric coated capsule with no active ingredient, taken twice daily
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Premysl Bercik, MD · McMaster University
-
Stephen Vanner, MD · Queens University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- QUADRUPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-07-15
- Primary Completion
- 2026-02-10
- Completion
- 2026-02-10
Countries
- Canada
Study Locations
More Related Trials
-
Multi Strain Probiotic Preparation in Patients With Irritable Bowel Syndrome
NCT04662957 ·Status: COMPLETED ·Phase: NA
-
The Efficacy of Single-strain Probiotics in Patients With Irritable Bowel Syndrome
NCT05064930 ·Status: COMPLETED ·Phase: NA
-
Brain and Gut Responses to Intragastric Administration of FODMAPs in Healthy Subjects and Patients With Irritable Bowel Syndrome
NCT04283487 ·Status: COMPLETED ·Phase: NA
-
Intracolonic FODMAP Infusion in Healthy Volunteers
NCT06488534 ·Status: COMPLETED ·Phase: NA
-
Nutrition to Relieve IBS Symptoms by Targeting the Microbiota
NCT04790422 ·Status: COMPLETED ·Phase: NA
-
Identification of IBS Metabotypes Based on Physiological Responses to Food
NCT03653689 ·Status: COMPLETED ·Phase: NA
-
The Impact of Dietary Treatment in Patients With Irritable Bowel Syndrome
NCT04307368 ·Status: COMPLETED ·Phase: NA
-
Is Microbiota Community Associated With Clinical Response to a Low FODMAP Diet in Patients With Irritable Bowel Syndrome
NCT02565550 ·Status: UNKNOWN ·Phase: PHASE4
-
Fructo-oligosaccharides and Irritable Bowel Syndrome
NCT00806104 ·Status: COMPLETED ·Phase: NA
-
Study of Bacteria on Mood and Bowel Symptoms in Patients With Irritable Bowel Syndrome
NCT01276626 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effects of Low FODMAP Diet on Colonic Epithelial Physiology in Diarrhea-predominant Irritable Bowel Syndrome
NCT04542018 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Probiotics Stabilized With Cryoprotection Technology in Patients With Irritable Bowel Syndrome
NCT04206410 ·Status: COMPLETED ·Phase: NA
-
Probiotics for Irritable Bowel Syndrome
NCT01151657 ·Status: COMPLETED ·Phase: NA
-
The Effects of Carbohydrates in Irritable Bowel Syndrome
NCT04830410 ·Status: COMPLETED ·Phase: NA
-
The Effect of Probiotics on Symptoms and Intestinal Flora in Patients With Irritable Bowel Syndrome
NCT02108119 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Two Probiotic Products on the Intestinal Barrier Function in Patients With Irritable Bowel Syndrome
NCT03986476 ·Status: COMPLETED ·Phase: NA
-
Irritable Bowel Syndrome and Food Sensitivity
NCT02186743 ·Status: COMPLETED ·Phase: NA
-
The Efficacy of Sodium Butyrate and Probiotics in Patients With Irritable Bowel Syndrome
NCT05013060 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Probiotic Bacteria in Subjects With IBS or Functional Diarrhea/ Bloating
NCT00618904 ·Status: COMPLETED ·Phase: NA
-
Study to Determine the Effectiveness of the Probiotic E. Coli Strain M17 in Treating Irritable Bowel Syndrome (IBS)
NCT00194922 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of FODMAPs on Mucosal Inflammation in IBS Patients
NCT03221790 ·Status: UNKNOWN ·Phase: NA
-
Effect of Bifidobacterium on Irritable Bowel Syndrome
NCT00737841 ·Status: UNKNOWN ·Phase: NA
-
Effects of Low FODMAP Diet on Leaky Gut
NCT04526808 ·Status: COMPLETED ·Phase: NA
-
Probiotics in the Treatment of Irritable Bowel Syndrome
NCT02953171 ·Status: UNKNOWN ·Phase: NA
-
Effect of BIO-K+ on Symptoms of Irritable Bowel Syndrome
NCT01545037 ·Status: COMPLETED ·Phase: PHASE2